Can Neuralink’s Blindsight brain chip really help the blind see? Explore the tech, trials, and reality behind Musk’s ...

Both 6-month trials were randomized, controlled studies that evaluated PER-001 delivered in a slow-release, dissolvable ...

Two examples of FDA-approved intracameral implants are Durysta (Allergan) and iDoseTR (Glaukos), both of which provide ...

In a statement, the Army said, "Army hospital R& R successfully performed Auditory brainstem implant - a rare, life-changing procedure in a 1.8-year-old d/o of a serving soldier, a case of Michel ...

SNS Insider Reveals Sharp Growth in U.S. Retinal Biologics Market, Valued at USD 9.70 Billion in 2023 Capturing Over 43% Global Share Amid FDA Approvals, VEGF-A Dominance, and Accelerating R&D in ...

Interventional glaucoma refers to the mindset that in first-line treatment for this condition, we consider procedural ...

Boehringer Ingelheim has raised hopes of a more patient-friendly option with the start of phase 2 testing of BI 1815368, ...

BVI is a winner in the Research and Development, Investments, and Product Launches categories in the 2025 Medical Device ...

Age-Related Macular Degeneration Market Epidemiology Report 2025-2035: Drugs Pipeline, Therapies, and Forecast The report provides a detail ...

BAYRY begins human trials for OpCT-001, an experimental cell therapy for treating primary photoreceptor diseases.

Pinhole pupilloplasty is a simple and low-cost solution to restore vision in patients with highly aberrated corneas and can ...

An argument found on the playground, at least in my day, was the one of "Who would win in a fight?" Thanks to Youtube many of ...